EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Reappraisal of Portal Vein Tumor Thrombosis as a Prognostic Factor for Patients with Hepatocellular Carcinoma

Young Chang iD, Su Jong Yu iD, Hyo-Cheol Kim iD, Yun Bin Lee iD, Eun Ju Cho iD, Jeong-Hoon Lee iD, Yoon Jun Kim iD, Jin Wook Chung iD, Jung-Hwan Yoon iD

Gut and Liver · 2024

DOI: 10.5009/gnl230057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gut and Liver, 2024. Verfasst von Young Chang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Digestive Research, Digestive Disease Center, Department of Internal Medicine, Soonchunhyang University College of Medicine, Seoul, Kor…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Chemoembolization, Therapeutic, Venous Thrombosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: : This study aimed to assess whether hepatocellular carcinoma (HCC) patients with portal vein tumor thrombosis (PVTT) could have favorable prognoses with proper treatment under selective conditions. Methods: : This retrospective, single-center study involved 1,168 patients diagnosed with HCC between January 2005 and December 2006, before the introduction of sorafenib. Overall survival (OS) was estimated using the Kaplan-Meier method, and the Cox proportional hazards model was used to identify and adjust the variables associated with OS. Results: : In nodular-type HCC, the OS differed significantly according to the presence of PVTT (log-rank p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsChemoembolization, TherapeuticVenous ThrombosisHumansPrognosisRetrospective StudiesPortal VeinTreatment Outcome

Stichwörter der Autor:innen

Hepatocellular carcinomaTherapeutic chemoembolizationThrombosis

Autor:innen und Institutionen

  • Institute for Digestive Research, Digestive Disease Center, Department of Internal Medicine, Soonchunhyang University College of Medicine, Seoul, Korea.
  • Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

ORCID-Profile: Young Chang, Su Jong Yu, Hyo-Cheol Kim, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Jin Wook Chung, Jung-Hwan Yoon

Zitieren

APA

Chang, Y., Yu, S. J., Kim, H. C., Lee, Y. B., Cho, E. J., Lee, J. H., Kim, Y. J., Chung, J. W., & Yoon, J. H. (2024). Reappraisal of Portal Vein Tumor Thrombosis as a Prognostic Factor for Patients with Hepatocellular Carcinoma. Gut and Liver. https://doi.org/10.5009/gnl230057

Vancouver

Chang Y, Yu SJ, Kim HC, Lee YB, Cho EJ, Lee JH, et al. Reappraisal of Portal Vein Tumor Thrombosis as a Prognostic Factor for Patients with Hepatocellular Carcinoma. Gut and Liver. 2024. doi:10.5009/gnl230057

BibTeX
@article{Chang2024,
  author = {Chang, Young and Yu, Su Jong and Kim, Hyo-Cheol and Lee, Yun Bin and Cho, Eun Ju and Lee, Jeong-Hoon and Kim, Yoon Jun and Chung, Jin Wook and Yoon, Jung-Hwan},
  title = {Reappraisal of Portal Vein Tumor Thrombosis as a Prognostic Factor for Patients with Hepatocellular Carcinoma},
  journal = {Gut and Liver},
  year = {2024},
  doi = {10.5009/gnl230057}
}
Kostenlos starten →